nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—SLC6A3—bipolar disorder	0.508	0.572	CbGaD
Methylphenidate—SLC6A4—bipolar disorder	0.38	0.428	CbGaD
Methylphenidate—SLC6A2—locus ceruleus—bipolar disorder	0.0158	0.302	CbGeAlD
Methylphenidate—SLC6A3—telencephalic ventricle—bipolar disorder	0.00927	0.177	CbGeAlD
Methylphenidate—SLC6A2—autonomic nervous system—bipolar disorder	0.00838	0.16	CbGeAlD
Methylphenidate—SLC6A3—Clearance of dopamine—COMT—bipolar disorder	0.00433	0.0748	CbGpPWpGaD
Methylphenidate—SLC6A3—Clearance of dopamine—MAOA—bipolar disorder	0.0043	0.0743	CbGpPWpGaD
Methylphenidate—SLC6A4—blood plasma—bipolar disorder	0.00405	0.0775	CbGeAlD
Methylphenidate—CYP2D6—urine—bipolar disorder	0.00374	0.0715	CbGeAlD
Methylphenidate—SLC6A4—Synaptic Vesicle Pathway—CPLX2—bipolar disorder	0.00347	0.0599	CbGpPWpGaD
Methylphenidate—SLC6A4—Serotonin Transporter Activity—TPH2—bipolar disorder	0.00332	0.0573	CbGpPWpGaD
Methylphenidate—SLC6A4—Serotonin Transporter Activity—MAOA—bipolar disorder	0.002	0.0345	CbGpPWpGaD
Methylphenidate—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—bipolar disorder	0.00198	0.0341	CbGpPWpGaD
Methylphenidate—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—bipolar disorder	0.00196	0.0339	CbGpPWpGaD
Methylphenidate—CYP2D6—blood plasma—bipolar disorder	0.00195	0.0373	CbGeAlD
Methylphenidate—SLC6A4—Synaptic Vesicle Pathway—CPLX1—bipolar disorder	0.0019	0.0328	CbGpPWpGaD
Methylphenidate—Dexmethylphenidate—SLC6A3—bipolar disorder	0.00163	0.572	CrCbGaD
Methylphenidate—SLC6A4—Monoamine Transport—TPH2—bipolar disorder	0.00141	0.0244	CbGpPWpGaD
Methylphenidate—SLC6A3—nervous system—bipolar disorder	0.00131	0.0251	CbGeAlD
Methylphenidate—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—bipolar disorder	0.00131	0.0227	CbGpPWpGaD
Methylphenidate—SLC6A3—cerebellum—bipolar disorder	0.00124	0.0237	CbGeAlD
Methylphenidate—Dexmethylphenidate—SLC6A4—bipolar disorder	0.00122	0.428	CrCbGaD
Methylphenidate—SLC6A2—Monoamine Transport—TPH2—bipolar disorder	0.00121	0.021	CbGpPWpGaD
Methylphenidate—SLC6A4—nervous system—bipolar disorder	0.0012	0.023	CbGeAlD
Methylphenidate—SLC6A3—Monoamine Transport—TPH2—bipolar disorder	0.00108	0.0186	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.00107	0.0186	CbGpPWpGaD
Methylphenidate—SLC6A2—nervous system—bipolar disorder	0.00106	0.0203	CbGeAlD
Methylphenidate—SLC6A4—Monoamine Transport—SLC6A3—bipolar disorder	0.00101	0.0174	CbGpPWpGaD
Methylphenidate—SLC6A3—brain—bipolar disorder	0.001	0.0192	CbGeAlD
Methylphenidate—SLC6A2—Monoamine Transport—SLC6A4—bipolar disorder	0.000971	0.0168	CbGpPWpGaD
Methylphenidate—SLC6A4—Serotonin Transporter Activity—IL1B—bipolar disorder	0.000965	0.0167	CbGpPWpGaD
Methylphenidate—SLC6A4—brain—bipolar disorder	0.00092	0.0176	CbGeAlD
Methylphenidate—SLC6A2—Amine compound SLC transporters—SLC6A3—bipolar disorder	0.000911	0.0157	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—SLC6A3—bipolar disorder	0.000866	0.015	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—SLC6A4—bipolar disorder	0.00086	0.0149	CbGpPWpGaD
Methylphenidate—SLC6A2—brain—bipolar disorder	0.00081	0.0155	CbGeAlD
Methylphenidate—SLC6A4—Synaptic Vesicle Pathway—SNAP25—bipolar disorder	0.000778	0.0134	CbGpPWpGaD
Methylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.00071	0.0123	CbGpPWpGaD
Methylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.000629	0.0109	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—SLC5A3—bipolar disorder	0.000595	0.0103	CbGpPWpGaD
Methylphenidate—CYP2D6—nervous system—bipolar disorder	0.000581	0.0111	CbGeAlD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.00056	0.00967	CbGpPWpGaD
Methylphenidate—CYP2D6—cerebellum—bipolar disorder	0.000546	0.0104	CbGeAlD
Methylphenidate—SLC6A2—NRF2 pathway—SLC5A3—bipolar disorder	0.000512	0.00884	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—NR1D1—bipolar disorder	0.000492	0.0085	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—CPLX1—bipolar disorder	0.000485	0.00838	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—SLC5A3—bipolar disorder	0.000453	0.00783	CbGpPWpGaD
Methylphenidate—CYP2D6—brain—bipolar disorder	0.000444	0.00849	CbGeAlD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.000437	0.00754	CbGpPWpGaD
Methylphenidate—SLC6A4—Monoamine Transport—IL1B—bipolar disorder	0.000411	0.00709	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.000398	0.00687	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.000398	0.00687	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—SERPINA1—bipolar disorder	0.000394	0.00681	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—CPLX1—bipolar disorder	0.000372	0.00642	CbGpPWpGaD
Methylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.000356	0.00616	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—IL1B—bipolar disorder	0.000353	0.0061	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—SERPINA1—bipolar disorder	0.000339	0.00586	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—CLOCK—bipolar disorder	0.000333	0.00576	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.000329	0.00569	CbGpPWpGaD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—MAOA—bipolar disorder	0.000328	0.00567	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—TPH2—bipolar disorder	0.000325	0.00561	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.000324	0.0056	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.000323	0.00557	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.000318	0.00549	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.000318	0.00549	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—IL1B—bipolar disorder	0.000313	0.0054	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.000309	0.00534	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—SERPINA1—bipolar disorder	0.0003	0.00519	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—SLC6A3—bipolar disorder	0.000299	0.00516	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—SLC6A4—bipolar disorder	0.000288	0.00498	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.000286	0.00494	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000285	0.00493	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.000279	0.00481	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.000273	0.00471	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.000267	0.00462	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD1—bipolar disorder	0.00026	0.00448	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—SLC6A3—bipolar disorder	0.000257	0.00444	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—SLC6A4—bipolar disorder	0.000255	0.00441	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000253	0.00437	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD3—bipolar disorder	0.000251	0.00434	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.000248	0.00429	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD4—bipolar disorder	0.000244	0.00422	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.000239	0.00413	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.000231	0.00399	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—NRG1—bipolar disorder	0.000228	0.00394	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD2—bipolar disorder	0.000227	0.00393	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000218	0.00377	CbGpPWpGaD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.000215	0.00372	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—GRIK2—bipolar disorder	0.000214	0.00369	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—GRIN1—bipolar disorder	0.000209	0.00361	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—NTRK1—bipolar disorder	0.000206	0.00356	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—GAD1—bipolar disorder	0.000205	0.00354	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000204	0.00352	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.000199	0.00343	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—NRG1—bipolar disorder	0.000196	0.00339	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000195	0.00337	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—CACNB2—bipolar disorder	0.00019	0.00329	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.00018	0.0031	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.000176	0.00304	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—NRG1—bipolar disorder	0.000174	0.003	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000164	0.00283	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.000162	0.0028	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—SNAP25—bipolar disorder	0.000152	0.00263	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—COMT—bipolar disorder	0.00015	0.0026	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.000149	0.00258	CbGpPWpGaD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000149	0.00257	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000145	0.00251	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—GRIN2B—bipolar disorder	0.000138	0.00238	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—ADCY2—bipolar disorder	0.000135	0.00233	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—GSK3B—bipolar disorder	0.000128	0.00221	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000124	0.00215	CbGpPWpGaD
Methylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000119	0.00206	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000116	0.002	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—COMT—bipolar disorder	0.000115	0.00199	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—MAOA—bipolar disorder	0.000114	0.00198	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00011	0.0019	CbGpPWpGaD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	9.68e-05	0.00167	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	8.23e-05	0.00142	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	8.17e-05	0.00141	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—COMT—bipolar disorder	7.95e-05	0.00137	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—MAOA—bipolar disorder	7.9e-05	0.00136	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	7.84e-05	0.00135	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ADCY2—bipolar disorder	7.24e-05	0.00125	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—IMPA2—bipolar disorder	6.81e-05	0.00118	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—POMC—bipolar disorder	5.14e-05	0.000888	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—IMPA1—bipolar disorder	4.6e-05	0.000794	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NDUFV2—bipolar disorder	3.91e-05	0.000675	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—AKR1C4—bipolar disorder	3.79e-05	0.000654	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NR1D1—bipolar disorder	3.4e-05	0.000587	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NCAN—bipolar disorder	3.25e-05	0.000562	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SLC5A3—bipolar disorder	3.19e-05	0.00055	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CLOCK—bipolar disorder	2.3e-05	0.000398	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—TSHB—bipolar disorder	2.24e-05	0.000388	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CACNB2—bipolar disorder	2.24e-05	0.000388	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—TPH2—bipolar disorder	2.24e-05	0.000388	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—DPYD—bipolar disorder	2.21e-05	0.000381	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CACNA1C—bipolar disorder	2.05e-05	0.000355	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	2e-05	0.000346	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.79e-05	0.00031	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.59e-05	0.000274	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—COMT—bipolar disorder	1.36e-05	0.000235	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—MAOA—bipolar disorder	1.35e-05	0.000233	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—MTHFR—bipolar disorder	1.1e-05	0.00019	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—POMC—bipolar disorder	8.79e-06	0.000152	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—INS—bipolar disorder	8.74e-06	0.000151	CbGpPWpGaD
